Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Recently Added News
US FDA Advisory Panel Will Review Sydnexis’ NDA for SYD-101 in Myopia
Sydnexis announced July 13 that the US FDA would convene an advisory committee meeting to discuss SYD-101, the company’s low-dose atropine candidate for pediatric progressive myopia. The date for t...
US FDA Recalls 2.5 Million Bottles of Prednisolone Acetate Eye Drops
The US FDA has issued a Class II recall of more than 2.5 million bottles of prednisolone acetate 1% eye drops manufactured by Lupin Limited, citing the possibility of foreign particulate contaminat...
Bausch + Lomb Drops Glaucoma Neuroprotection Program after Phase II Failure
Bausch + Lomb announced July 10 that it would discontinue development of a neuroprotective eye drop candidate for glaucoma, citing Phase II results in which BL1107, a prodrug of brimonidine tartrat...
RxSight Appoints Aziz Mottiwala as President, CEO
RxSight reported July 15 that it had appointedAziz Mottiwala as president and chief executive officer, effective July 20. Mottiwala succeeds Ron Kurtz, MD, who will continue to serve as chief medic...
J&J Vision Generates Q2-2026 Surgical Revenue of $426 Million
J&J Vision’s Q2-2026 global surgical revenue totaled $426 million, a 5.6 percent increase over $403 million in Q2-2025, parent Johnson & Johnson, of New Brunswick, New Jersey, reported July 15. Q2-...
Tarsus Acquires iRenix, Developer of Pre-procedure Ocular Antiseptic Candidate
Tarsus Pharmaceuticals announced July 8 that it had acquired iRenix Medical, of Palo Alto, California, developer of IRX-101, an investigational ocular antiseptic. Tarsus said it would pay approxima...
Tenpoint Submits UK Marketing Application for Yuvezzi Presbyopia Drops
Tenpoint Therapeutics reported July 13 that it had submitted a marketing authorization application to the UK’s Medicines and Healthcare Products Regulatory Agency for Yuvezzi (carbachol and brimoni...
Hengrui’s Cyclosporine Eye Drop Formulation for Dry Eye Gains Approval in China
China’s Hengrui Pharmaceuticals and Germany’s Novaliq announced June 30 that China’s National Medical Products Administration had approved Heng Yi (0.1% cyclosporine ophthalmic solution) for dry ey...
Vivani’s Cortigent to Merge with Nasdaq-Listed ClearOne
Vivani Medical, of Alameda, California, reported July 2 that its Cortigent subsidiary— which is developing the Orion visual cortex implant—would merge with Nasdaq-listed ClearOne to form Cortigent ...
Alcon and RxSight to Collaborate on Developing Adjustable PC-IOLs
Alcon and RxSight willjointly develop adjustable presbyopia-correcting intraocular lenses (PC-IOLs) under a new nonexclusive agreement, the companies announced July 6. The collaboration aims to com...
Harrow Relaunches Lucentis Biosimilar Byooviz in the US
Harrow announced July 1 that it had relaunched Byooviz (ranibizumab-nuna), a Lucentis biosimilar, in the US. The Nashville, Tennessee, company secured US rights to Byooviz and another ophthalmic bi...
LensCrafters Adds Refractive and Cataract Surgery Options to New Center
LensCrafters, part of French company EssilorLuxottica, announced June 30 that it was launching the first LensCrafters Vision & Eye Health Center, addingsurgical procedures and advanced diagnostics ...
Past News Stories
US FDA Accepts sBLA for Genentech Subcutaneous TED Candidate, Grants Priority Review
Genentech announced June 30 that the US FDA had accepted its supplemental biologics license application (sBLA) for subcutaneous Enspryng (satralizumab) in thyroid eye disease (TED). The agency gran...
Global Team of Ophthalmologists Creates Questionnaire for Reporting Dysphotopsias
Twenty multinational ophthalmic specialists, including key opinion leaders, have developed a consensus-based classification system and questionnaire for reporting dysphotopsias after ophthalmic pro...
Bausch + Lomb Rolls Out Orphia Digital Platform, Initially Focused on Patient Education
Bausch + Lomb reported July 9 the introduction of Orphia, a new AI-powered digital health platform intended to increase eye care providers’ efficiency. It will initially provide pre-surgery catarac...
Researchers Develop Dry Eye Candidate Powered by Spinach and Light
Researchers in Singapore have developed a spinach-derived nanotechnology that enables corneal cells to produce a key antioxidant molecule when exposed to ambient light. The team at the National Uni...
HelpMeSee Accelerates MSICS Training in India with New Center in Guwahati
Global nonprofit group HelpMeSee and its Indian subsidiary, HMS Vision Private Limited, have launched virtual training for manual small incision cataract surgery (MSICS) in Guwahati, India. Trainin...
New Marketplace Aims to Rescue Shelved Cell and Gene Therapies
Hundreds of cell and gene therapy (CGT) candidates have been shelved in recent years—not because they failed patients, but because they weren’t considered commercially viable. A new joint venture a...
MACs Propose Limiting Coverage for iDose TR
Five Medicare administrative contractors (MACs) in the US are proposing to limit coverage for procedures implanting the Glaukos iDose TR in patients with glaucoma. The iDose TR is a drug-eluting in...
Viridian Announces US FDA Approval and Launch of Lumvoa for Thyroid Eye Disease
Viridian Therapeutics announced June 29 that the US FDA had approved Lumvoa (veligrotug-vvze), an infusion treatment for thyroid eye disease (TED). The Waltham, Massachusetts, company said it would...
Lenz Licenses Vizz Presbyopia Drops to Arrotex for Australia, New Zealand
Lenz Therapeutics announced June 24 that it had granted Arrotex Pharmaceuticals exclusive rights to develop Vizz (aceclidine ophthalmic solution) 1.44% eye drops for presbyopia in Australia and New...
LambdaVision Collaborates with Vast, Creator of Planned Commercial Space Station
LambdaVision reported June 24 that it had signed a memorandum of understanding with Vast related to future research and manufacturing activities for LambdaVision’s artificial retina aboard Vast’s p...
Supreme Court Ruling in Favor of Bayer May Shut Down Thousands of Roundup Lawsuits
German company Bayer won a landmark ruling in the US Supreme Court on June 25, when justices ruled 7-2 that federal pesticide laws preempt “failure-to-warn” claims made under state law. The plainti...
Optos Celebrates Milestone of 30 Thousand Installed Imaging Devices
UK-based Optos reported June 25 that it had reached the milestone of 30 thousand imaging devices installed globally. The company developed and continues to be a leader in single-capture, 200-degree...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.